These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9834999)

  • 21. Magnetic resonance evaluation of luminal patency after polylactide stent implantation: an experimental study in a rabbit aorta model.
    Hietala EM; Maasilta P; Ståhls A; Salminen US; Harjula AL; Välimaa T; Kivisaari L
    Eur Radiol; 2003 May; 13(5):1025-32. PubMed ID: 12695824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model.
    Shen L; Wu Y; Ge L; Zhang Y; Wang Q; Qian J; Qiu Z; Ge J
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1473-1481. PubMed ID: 28639098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nitinol Strecker stent placement on vascular response in normal and stenotic porcine iliac arteries.
    Froelich JJ; Alfke H; Wilke A; Ramaswamy A; Barth KH; Hoppe M; Wagner HJ; Klose KJ
    J Vasc Interv Radiol; 1999 Mar; 10(3):329-38. PubMed ID: 10102199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon-coated stents implanted in porcine iliac and renal arteries: histologic and histomorphometric study.
    Galloni M; Prunotto M; Santarelli A; Laborde F; Dibie A; Isaia C; Monari E; Gatti AM; Pasquino E
    J Vasc Interv Radiol; 2003 Aug; 14(8):1053-61. PubMed ID: 12902564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
    Berg R; Aragon J; Royter V; Shanley JF; Cogert G; Vermani R; Kar S; Eigler N; Litvack F
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):871-9. PubMed ID: 17932889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges.
    Gogas BD; Benham JJ; Hsu S; Sheehy A; Lefer DJ; Goodchild TT; Polhemus DJ; Bouchi YH; Hung OY; Yoo SY; Joshi U; Giddens DP; Veneziani A; Quyyumi A; Rapoza R; King SB; Samady H
    JACC Cardiovasc Interv; 2016 Apr; 9(7):728-41. PubMed ID: 27056313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents.
    Holmes DR; Camrud AR; Jorgenson MA; Edwards WD; Schwartz RS
    J Am Coll Cardiol; 1994 Aug; 24(2):525-31. PubMed ID: 8034892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.
    Uurto I; Mikkonen J; Parkkinen J; Keski-Nisula L; Nevalainen T; Kellomäki M; Törmälä P; Salenius JP
    J Endovasc Ther; 2005 Jun; 12(3):371-9. PubMed ID: 15943514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
    Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
    Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local methylprednisolone inhibition of foreign body response to coated intracoronary stents.
    de Scheerder I; Wang K; Wilczek K; van Dorpe J; Verbeken E; Desmet W; Schacht E; Piessens J
    Coron Artery Dis; 1996 Feb; 7(2):161-6. PubMed ID: 8813449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
    Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interpreting arterial wall inflammation around stents in the porcine coronary artery model.
    Wilson GJ
    J Vasc Interv Radiol; 2011 Feb; 22(2):260-1. PubMed ID: 21276920
    [No Abstract]   [Full Text] [Related]  

  • 36. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
    Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
    Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiopeptin-eluting stents: observations in human vessels and pig coronary arteries.
    Armstrong J; Gunn J; Arnold N; Malik N; Chan KH; Vick T; Stratford P; Cumberland DC; Holt CM
    J Invasive Cardiol; 2002 May; 14(5):230-8. PubMed ID: 11983942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual drug release from stents-will we be happy with thing one and thing two?
    Hehrlein C
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):880. PubMed ID: 18022914
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents.
    Henn C; Satzl S; Christoph P; Kurz P; Radeleff B; Stampfl U; Stampfl S; Berger I; Richter GM
    J Vasc Interv Radiol; 2008 Mar; 19(3):427-37. PubMed ID: 18295704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a polymer endovascular prosthesis and its implantation in porcine arteries.
    van der Giessen WJ; Slager CJ; van Beusekom HM; van Ingen Schenau DS; Huijts RA; Schuurbiers JC; de Klein WJ; Serruys PW; Verdouw PD
    J Interv Cardiol; 1992 Sep; 5(3):175-85. PubMed ID: 10150957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.